Can a 15-year-old with ADHD and bipolar, currently taking aripiprazole 10 mg daily and clonidine 0.1 mg daily, who has discontinued valproic acid (Depakote), start lamotrigine (Lamictal) daily now after beginning 25 mg every other day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, you can now start lamotrigine daily at 25 mg/day since Depakote has been discontinued.

Now that valproic acid (Depakote) is completely discontinued, you should transition from the every-other-day dosing to daily lamotrigine 25 mg/day and follow the standard titration schedule without valproate co-administration. 1

Key Rationale

The every-other-day dosing was appropriate during the Depakote taper because valproate dramatically increases lamotrigine levels by approximately 2-fold and doubles its half-life 1, 2. This interaction occurs because valproate inhibits lamotrigine glucuronidation, requiring much slower titration and lower target doses when the drugs are combined 2.

With Depakote now discontinued:

  • The inhibitory effect on lamotrigine metabolism is gone
  • Standard dosing schedules now apply
  • The risk of serious rash (which is higher with concurrent valproate) is reduced 1

Standard Lamotrigine Titration Schedule (Without Valproate)

For this 15-year-old with bipolar disorder on aripiprazole and clonidine:

Weeks 1-2: 25 mg daily
Weeks 3-4: 50 mg daily
Week 5: 100 mg daily
Week 6: 200 mg daily (typical target dose)

1

Critical Safety Considerations

Monitor closely for rash, especially in the first 2-8 weeks - this is the highest risk period for serious skin reactions including Stevens-Johnson syndrome. The risk is elevated in adolescents aged 2-16 years compared to adults 1. Instruct the patient/family to immediately report:

  • Any skin rash
  • Blistering or peeling
  • Painful mouth sores
  • Fever with rash

The current medication combination is safe: Aripiprazole causes only a minimal 10% reduction in lamotrigine levels, which is not clinically significant and requires no dose adjustment 1, 3. Clonidine has no known interaction with lamotrigine.

Important Clinical Pitfall

Do not rush the titration schedule even though Depakote is discontinued. The slow titration is essential to minimize rash risk regardless of other medications 1. The standard 6-week titration to 200 mg/day remains the safest approach for this adolescent patient.

References

2
Research

Bidirectional interaction of valproate and lamotrigine in healthy subjects.

Clinical pharmacology and therapeutics, 1996

Related Questions

In bipolar I disorder, is Lamictal (lamotrigine) 400 mg appropriate when no enzyme‑inducing medication is being taken?
In a patient on aripiprazole 15 mg daily who is developing hypomanic symptoms, does lamotrigine provide enough benefit to emotional reactivity to justify continuing it?
What is the appropriate next step in management for a 61-year-old woman with bipolar II disorder, a history of drug use in remission, currently taking quetiapine (Seroquel) 300 mg at bedtime, who reports a persistent low mood without the typical cycling?
Should the aripiprazole dose be increased from 15 mg daily for a patient with ongoing hypomania, disorganization, and anxiety while on lamotrigine 200 mg daily?
Can I stop lamictal (lamotrigine) 25mg daily abruptly?
What is the appropriate treatment for a pressure ulcer located on the lumbar spine?
What labs should be ordered for a child with weight loss and refusal of solid foods to evaluate anemia, iron deficiency, celiac disease, eosinophilic esophagitis, and micronutrient deficiencies?
For a client who has been off all prescribed psychotropic medications for two weeks, reports feeling fine, wants to discontinue them permanently, and has a supportive relative, what is the recommended plan for safely tapering and monitoring the discontinuation?
In a patient with dyspnea, a normal chest X‑ray (no pneumonia) and a negative CT pulmonary angiogram (no pulmonary embolism), what are the likely causes of the shortness of breath?
Can enoxaparin (Lovenox) be given to a patient with a documented heparin allergy?
Can a dentist perform tooth extraction at the bedside for a patient scheduled for aortic valve replacement (AVR)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.